Prion diseases, update

Tetsuyuki Kitamoto

Research output: Contribution to journalArticlepeer-review


In prion diseases, genotypic classification has been useful to understand the clinical course and pathological changes. However, among patients with the same prion protein (PrP) genotype, there are variations in the pathological and clinical phenotype. Recently, PrP typing was proposed by the molecular weight of protease-resistant PrP (PrPres). Combined with genotype and PrPres typing, sporadic Creutzfeldt-Jakob disease (CJD) could be classified precisely. In addition, we found the fragmented PrP molecules to differentiate between dura-classic CJD and dura-plaque type CJD. We report herein that the fragmented PrP is a useful marker to classify human prion diseases, and also a clue to analyze abnormal PrP structures. The fragmented PrP was detected in patients with classic-type CJD, sporadic thalamic-type CJD, familial CJD with codon 200 or 232 mutation, or familial Gerstmann-Straussler syndrome (GSS) with codon 102 mutation. Among patients with type-1 abnormal PrP, the transmission study was successful in sporadic CJD with type 1 PrPres and the fragment PrP, but not in CJD without the fragmented PrP. Thus, in the prion field, type-specific PrP structure contributes to the clinicopathology and transmissibility.

Original languageEnglish
Pages (from-to)1223-1225
Number of pages3
JournalClinical Neurology
Issue number12
Publication statusPublished - 2001 Dec 1


  • Abnormal isoform of PrP
  • Fragmented PrP
  • Prion diseases
  • Typing

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Prion diseases, update'. Together they form a unique fingerprint.

Cite this